Kainos Medicine, Inc. (KOSDAQ: 284620)

Kainos Medicine Statistics

Total Valuation

Kainos Medicine has a market cap or net worth of KRW 112.58 billion.

Market Cap	112.58B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Kainos Medicine has 28.18 million shares outstanding.

Shares Outstanding	28.18M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.53%
Owned by Institutions (%)	n/a
Float	25.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.09
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.20% and return on invested capital (ROIC) is 0.19%.

Return on Equity (ROE)	0.20%
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	0.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.50%
50-Day Moving Average	4,130.80
200-Day Moving Average	4,095.10
Relative Strength Index (RSI)	43.89
Average Volume (20 Days)	74,715

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	60.74M
Pretax Income	60.74M
Net Income	39.92M
EBITDA	n/a
EBIT	60.74M
Earnings Per Share (EPS)	6.18

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	19.83B
Book Value Per Share	3,672.38
Working Capital	n/a

Cash Flow

Operating Cash Flow	169.79M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Kainos Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,474.97%
Shareholder Yield	-1,474.97%
Earnings Yield	0.15%
FCF Yield	n/a

Stock Splits

The last stock split was on June 24, 2022. It was a reverse split with a ratio of 0.2.

Last Split Date	Jun 24, 2022
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a